Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs121909237
rs121909237
PTEN
G 0.800 CausalMutation CLINVAR

dbSNP: rs1064793881
rs1064793881
TP53
T 0.700 GeneticVariation CLINVAR

dbSNP: rs121909250
rs121909250
ING1
C 0.700 CausalMutation CLINVAR

dbSNP: rs121909251
rs121909251
ING1
G 0.700 CausalMutation CLINVAR

dbSNP: rs121909252
rs121909252
ING1
A 0.700 CausalMutation CLINVAR

dbSNP: rs121912664
rs121912664
TP53
T 0.700 CausalMutation CLINVAR

dbSNP: rs1567549584
rs1567549584
TP53
C 0.700 GeneticVariation CLINVAR

dbSNP: rs201613442
rs201613442
TNNI3K ; FPGT-TNNI3K ; LRRC53
0.700 GeneticVariation UNIPROT

dbSNP: rs397514495
rs397514495
TP53
T 0.700 GeneticVariation CLINVAR

dbSNP: rs587782144
rs587782144
TP53
G 0.700 GeneticVariation CLINVAR

dbSNP: rs121909237
rs121909237
PTEN
0.800 GeneticVariation UNIPROT Detection of new PTEN/MMAC1 mutations in head and neck squamous cell carcinomas with loss of chromosome 10. 11801303

2002
dbSNP: rs861539
rs861539
KLC1 ; XRCC3
0.040 GeneticVariation BEFREE In a hospital-based case-control study, we tested the hypothesis that a C to T variant (Thr241Met) of DNA repair gene X-ray repair cross-complementing group 3 (XRCC3) is associated with risk of developing squamous cell carcinoma of the head and neck (SCCHN). 12115490

2002
dbSNP: rs1057519991
rs1057519991
TP53
0.710 GeneticVariation BEFREE Combinations of the Y113H and H139R polymorphic EPHX1 variants have been assumed to alter the enzyme activity and thus the risk of squamous cell head and neck cancer (SCCHN). 12491039

2003
dbSNP: rs1051740
rs1051740
EPHX1
0.010 GeneticVariation BEFREE Combinations of the Y113H and H139R polymorphic EPHX1 variants have been assumed to alter the enzyme activity and thus the risk of squamous cell head and neck cancer (SCCHN). 12491039

2003
dbSNP: rs2234922
rs2234922
EPHX1
0.010 GeneticVariation BEFREE Combinations of the Y113H and H139R polymorphic EPHX1 variants have been assumed to alter the enzyme activity and thus the risk of squamous cell head and neck cancer (SCCHN). 12491039

2003
dbSNP: rs876659477
rs876659477
TP53
0.010 GeneticVariation BEFREE Combinations of the Y113H and H139R polymorphic EPHX1 variants have been assumed to alter the enzyme activity and thus the risk of squamous cell head and neck cancer (SCCHN). 12491039

2003
dbSNP: rs11549465
rs11549465
HIF1A ; HIF1A-AS3
0.010 GeneticVariation BEFREE We assessed the difference in transcription activity of two HIF-1alpha polymorphic variants (P582S and A588T), along with molecular epidemiological study among head and neck squamous cell carcinoma (HNSCC) patients. 12919954

2003
dbSNP: rs11549467
rs11549467
HIF1A ; HIF1A-AS3
0.010 GeneticVariation BEFREE We assessed the difference in transcription activity of two HIF-1alpha polymorphic variants (P582S and A588T), along with molecular epidemiological study among head and neck squamous cell carcinoma (HNSCC) patients. 12919954

2003
dbSNP: rs1799782
rs1799782
XRCC1
0.060 GeneticVariation BEFREE In conclusion, the result from our study provides additional evidence of an association of the XRCC1 polymorphism (Arg194Trp) with SCCHN as markers of genetic susceptibility in the Korean population. 15252855

2004
dbSNP: rs1695
rs1695
GSTP1
0.050 GeneticVariation BEFREE We hypothesized that head and neck squamous cell carcinoma (HNSCC) might respond differently to chemotherapeutic agents, especially cisplatin (CDDP) because of the presence of GSTP1 I105V polymorphism. 15254763

2004
dbSNP: rs1801394
rs1801394
MTRR ; FASTKD3
0.020 GeneticVariation BEFREE In conclusion, our data provide evidence that support the association between the MTR A2756G and MTRR G66A polymorphisms and SCCHN risk and that these two polymorphisms may have a joint effect on risk of SCCHN. 15894670

2005
dbSNP: rs1805087
rs1805087
MTR
0.020 GeneticVariation BEFREE In conclusion, our data provide evidence that support the association between the MTR A2756G and MTRR G66A polymorphisms and SCCHN risk and that these two polymorphisms may have a joint effect on risk of SCCHN. 15894670

2005
dbSNP: rs1052133
rs1052133
OGG1 ; CAMK1
0.040 GeneticVariation BEFREE Our present data suggest a possible interaction between the OGG1 Ser326Cys polymorphism and smoking in HNSCC. 16381036

2006
dbSNP: rs1042028
rs1042028
SULT1A1
0.010 GeneticVariation BEFREE The purpose of this study was to evaluate whether SULT1A1 Arg213His polymorphisms are risk factors for head and neck squamous cell carcinoma (SCCHN). 16575574

2006
dbSNP: rs9282861
rs9282861
SULT1A1
0.010 GeneticVariation BEFREE The purpose of this study was to evaluate whether SULT1A1 Arg213His polymorphisms are risk factors for head and neck squamous cell carcinoma (SCCHN). 16575574

2006